Global Health logo

GLH - Global Health Share Price

A$0.27 0.0  0.0%

Last Trade - 12/08/20

Sector
Technology
Size
Micro Cap
Market Cap £6.22m
Enterprise Value £6.36m
Revenue £3.25m
Position in Universe 1450th / 1831
Bullish
Bearish
Unlock GLH Revenue
Momentum
Relative Strength (%)
1m +4.80%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -28.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
5.25 4.54 5.03 10.1 5.17 5.52 +1.0%
+9.9 -26.7 -90.1 +2,141
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2019, Global Health Limited revenues increased 18% to A$2.8M. Net loss increased 1% to A$506K. Revenues reflect Revenue from the licenses subscriptions increase of 46% to A$2.8M. Higher net loss reflects Amortisation increase from A$66K to A$178K (expense), Depreciation increase from A$35K to A$87K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -A$0.01.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

GLH Revenue Unlock GLH Revenue

Net Income

GLH Net Income Unlock GLH Revenue

Normalised EPS

GLH Normalised EPS Unlock GLH Revenue

PE Ratio Range

GLH PE Ratio Range Unlock GLH Revenue

Dividend Yield Range

GLH Dividend Yield Range Unlock GLH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GLH EPS Forecasts Unlock GLH Revenue
Profile Summary

Global Health Limited is engaged in the development, sales and support of application software for the healthcare sector. The Company is also engaged in the development of systems integration software that enables data to be securely exchanged between multiple, disparate applications within an enterprise and across the healthcare value chain. The Company's segments include Acute, which consists of information system applications for the hospital and day surgery market to deliver integrated healthcare; Non-Acute, which consists of a suite of applications that provide the management of population outcomes for communities of common interest; Other, which consists of products and services delivered to non-healthcare customers, and includes revenues and expenses associated with third party products and cost recoveries from customers, and Corporate. Its products include MasterCare MHAGIC and MasterCare Data Warehouse. It offers HotHealth Website for medical practice or health business.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated January 28, 2000
Public Since April 4, 2000
No. of Shareholders: n/a
No. of Employees: 49
Sector Technology
Industry Software & IT Services
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 42,098,320
Free Float (0.0%)
Eligible for
ISAs
SIPPs
GLH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for GLH
Upcoming Events for GLH
Frequently Asked Questions for Global Health
What is the Global Health share price?

As of 12/08/20, shares in Global Health are trading at A$0.27, giving the company a market capitalisation of £6.22m. This share price information is delayed by 15 minutes.

How has the Global Health share price performed this year?

Shares in Global Health are currently trading at A$0.27 and the price has moved by 92.08% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Global Health price has moved by 0.100k% over the past year.

What are the analyst and broker recommendations for Global Health?

There are no analysts currently covering Global Health.

When will Global Health next release its financial results?

Global Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Global Health dividend yield?

Global Health does not currently pay a dividend.

Does Global Health pay a dividend?

Global Health does not currently pay a dividend.

When does Global Health next pay dividends?

Global Health does not currently pay a dividend.

How do I buy Global Health shares?

To buy shares in Global Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Global Health?

Shares in Global Health are currently trading at A$0.27, giving the company a market capitalisation of £6.22m.

Where are Global Health shares listed? Where are Global Health shares listed?

Here are the trading details for Global Health:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: GLH
What kind of share is Global Health?

Based on an overall assessment of its quality, value and momentum, Global Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Global Health share price forecast 2020?

We were not able to load any forecast data for Global Health.

How can I tell whether the Global Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Global Health. Over the past six months, the relative strength of its shares against the market has been 0.124k%. At the current price of A$0.27, shares in Global Health are trading at 58.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Global Health PE Ratio?

We were not able to find PE ratio data for Global Health.

Who are the key directors of Global Health?

Global Health's management team is headed by:

Steven Pynt - NEC
Mathew Cherian - CEO
Stuart Smith - NID
Robert Knowles - NID
Islah Ishak - GMG
Sam Butcher - SEC
Who are the major shareholders of Global Health?

Here are the top five shareholders of Global Health based on the size of their shareholding:

Cherian (Alumootil Mathew ) Individual Investor
Percentage owned: 55.53% (23.4m shares)
Thomas (Elizabeth May Priscilla) Individual Investor
Percentage owned: 3.64% (1.53m shares)
Lim (Serene) Individual Investor
Percentage owned: 2.16% (910k shares)
Connaught Consultants (Finance) Pty. Ltd. Corporation
Percentage owned: 1.74% (731k shares)
Triglobal Management Limited Corporation
Percentage owned: 1.19% (500k shares)
Similar to GLH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.